253 related articles for article (PubMed ID: 22740985)
1. Proteomic studies in breast cancer (Review).
Qin XJ; Ling BX
Oncol Lett; 2012 Apr; 3(4):735-743. PubMed ID: 22740985
[TBL] [Abstract][Full Text] [Related]
2. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
3. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
Bakry R; Rainer M; Huck CW; Bonn GK
Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
[TBL] [Abstract][Full Text] [Related]
4. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
Cazares LH; Diaz JI; Drake RR; Semmes OJ
Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
[TBL] [Abstract][Full Text] [Related]
5. Advances in MALDI mass spectrometry in clinical diagnostic applications.
Ng EW; Wong MY; Poon TC
Top Curr Chem; 2014; 336():139-75. PubMed ID: 23563502
[TBL] [Abstract][Full Text] [Related]
6. Applications of Surface-Enhanced Laser Desorption/Ionization Time-Of-Flight (SELDI-TOF) Mass Spectrometry in Defining Salivary Proteomic Profiles.
Al-Tarawneh SK; Bencharit S
Open Dent J; 2009 Apr; 3():74-9. PubMed ID: 19543543
[TBL] [Abstract][Full Text] [Related]
7. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
[TBL] [Abstract][Full Text] [Related]
8. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
9. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
10. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
11. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Seibert V; Ebert MP; Buschmann T
Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
[TBL] [Abstract][Full Text] [Related]
12. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
Gonçalves A; Bertucci F; Birnbaum D; Borg JP
Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
[TBL] [Abstract][Full Text] [Related]
13. SELDI-TOF proteomic analysis and cancer detection.
Henderson NA; Steele RJ
Surgeon; 2005 Dec; 3(6):383-90, 422. PubMed ID: 16353858
[TBL] [Abstract][Full Text] [Related]
14. Novel possibilities in the study of the salivary proteomic profile using SELDI-TOF/MS technology.
Ardito F; Perrone D; Cocchi R; Lo Russo L; DE Lillo A; Giannatempo G; Lo Muzio L
Oncol Lett; 2016 Mar; 11(3):1967-1972. PubMed ID: 26998108
[TBL] [Abstract][Full Text] [Related]
15. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
Solassol J; Marin P; Maudelonde T; Mangé A
Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
[TBL] [Abstract][Full Text] [Related]
16. Comparative Proteomic Analysis of Three Gelatinous Chinese Medicines and Their Authentications by Tryptic-digested Peptides Profiling using Matrix-assisted Laser Desorption/Ionization-time of Flight/Time of Flight Mass Spectrometry.
Yang H; Zheng J; Wang HY; Li N; Yang YY; Shen YP
Pharmacogn Mag; 2017; 13(52):663-667. PubMed ID: 29200730
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of intact mycobacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Hettick JM; Kashon ML; Simpson JP; Siegel PD; Mazurek GH; Weissman DN
Anal Chem; 2004 Oct; 76(19):5769-76. PubMed ID: 15456297
[TBL] [Abstract][Full Text] [Related]
18. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
19. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.
Bouamrani A; Ternier J; Ratel D; Benabid AL; Issartel JP; Brambilla E; Berger F
Clin Chem; 2006 Nov; 52(11):2103-6. PubMed ID: 16990423
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics strategies for proteomic profiling.
White CN; Chan DW; Zhang Z
Clin Biochem; 2004 Jul; 37(7):636-41. PubMed ID: 15234244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
